AstraZeneca Articles
Dr Reddy's calls bluff on AZ's Nexium patent
16 June 2008
Alnylam completes deal with Tekmira
9 June 2008
Stock Commentary - Europe - week to June 2, 2008
9 June 2008
AZ submits sNDA for Symbicot in pediatric asthma
9 June 2008
Major cutbacks to drug salesforces, ABPI warns
9 June 2008
EC targets Sanofi for "obstruction"
9 June 2008
Barr confirms Entocort patent challenge
2 June 2008
Stock Commentary - Europe - week to May 26, 2008
2 June 2008
ABPI collaborates with NHS PCT on COPD care
2 June 2008
Studies find genetic susceptibility to COPD
2 June 2008
Shionogi's Crestor boosts fiscal 2007
2 June 2008
GSK shareholders protest at AGM
2 June 2008
Stock Commentary - Europe - week to May 19, 2008
26 May 2008
Japan stock market week to May 19, 2008
26 May 2008
CR UK to develop AstraZeneca drug
26 May 2008
Pharma M&A rumor mill in top gear
26 May 2008
Stock Commentary - Europe - week to May 12, 2008
19 May 2008
AZ submits sNDA for Seroquel to treat GAD
19 May 2008
AZ asthma candidate enters Ph I trials
19 May 2008
Retail drug sales in year to February 2008
19 May 2008
Seroquel XR fares well in MDD and GAD
19 May 2008
AstraZeneca submits MAA for Iressa
12 May 2008
Albireo secures 25M euro financing
12 May 2008
EPO revokes a Symbicort patent
12 May 2008
J&J drug: longer time to relapse than quetiapine
12 May 2008
Wal-Mart expands drug program to 90 days
12 May 2008
ARB switching strategy may not result in long-term savings within a five-year model, says Merck & Co
12 May 2008
AstraZeneca submits Symbicort sNDA to US FDA
5 May 2008
Merck & Co 1Q results saved by AZ payout
28 April 2008
Stock Commentary - Europe - week to April 21, 2008
28 April 2008
AZ to work with Wash Uni on Alzheimer's
28 April 2008
Final FDA appro for Mylan's felodipine
28 April 2008
Capital Group cuts stake in AstraZeneca
28 April 2008
Spanish company news in brief
21 April 2008
Retail drug sales in year to January 2008
21 April 2008
Stock Commentary - Europe - week to April 7, 2008
14 April 2008
MAP0005 comparable FEV1 to Symbicort
14 April 2008
India NGOs at war with cancer drug patents
7 April 2008
Stock Commentary - Europe - week to Mach 31, 2008
7 April 2008
Positive outlook for AstraZeneca's Recentin
7 April 2008
Crestor sales hopes raised by JUPITER trial
7 April 2008
Crestor causes atherosclerosis regression
7 April 2008
Zetia "could be expensive placebo," ACC hears
7 April 2008
Silence Thera's 2007 revenue doubles
7 April 2008
FDA investigates suicide link with Singulair
7 April 2008
Peter Edman becomes CSO at Biovitrum
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
LB analysts: Shire is "heavily" over-valued
31 March 2008
11 defendants settle US AWP litigation
24 March 2008
Stock Commentary - Europe - week to March 17, 2008
24 March 2008
CORRECTION: Ethiopia/AstraZeneca breast cancer project
24 March 2008
Drug industry in 2020, at Economist
17 March 2008
Stock Commentary - Europe - week to March 10, 2008
17 March 2008
AstraZeneca enrolls vandetanib Ph III trial in NSCLC
17 March 2008
Project changes Ethiopia's breast cancer paradigm
17 March 2008
Promotional spending on atypical antipsychotice analyzed
17 March 2008
KV's fiscal 3rd-qtr net revenue jumps 39%
17 March 2008
US FDA begins safety review of LABA asthma drugs
10 March 2008
Perrigo begins shipping omeprazole
10 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
Merck & Co sells JV products to AZ
10 March 2008
Seroquel XR filed with FDA for MDD
10 March 2008
Stock Commentary - Europe - week to Feb 25, 2008
3 March 2008
FDA OKs Nexium for GERD in one-11 year olds
3 March 2008
Mixed Ph II data on AstraZeneca's Recentin
3 March 2008
Mixed Ph II data on AstraZeneca's Recentin
3 March 2008
Watson swings to profit of $38.4M in 4th qtr
3 March 2008
AstraZeneca to appeal $215M Ala damages
3 March 2008
Stock Commentary - Europe - week to Feb 18, 2008
25 February 2008
Pinnacle and MedImmune sign Ethyol distribution deal
25 February 2008
Doctors claim statins cause memory loss
25 February 2008
AstraZeneca files Seroquel for MDD with MHRA
25 February 2008
Bentley's generic Losec wins European approval
18 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
AstraZeneca files for new Seroquel indication in EU
18 February 2008
Meditrina in deal with AstraZeneca
18 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
AstraZeneca's net profit falls 12% on restructing charges from MedImmune buy, lower Nexium sales
11 February 2008
AstraZeneca 4th-qtr sales rise 8%
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
AstraZeneca's Seroquel cuts rate of mood events
4 February 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
